Syneron gets FDA nod for thigh reduction device - Cellulite Reduction Treatment

Syneron gets FDA nod for thigh reduction device
Aug 8, 2007
Reuters

Israel's Syneron Medical Ltd. (ELOS.O: Quote, Profile, Research), which provides laser-based services, said it received regulatory pre-marketing clearance for its device for temporary reduction of thigh circumference.

The Vela platform had earlier received the U.S. Food and Drug Administration's approval for cellulite treatment, the company said in a statement.

The company also got regulatory approval to market the device in the European Union, Syneron added.

(Reporting by Aditi Samajpati in Bangalore)

((Editing by Jarshad Kakkrakandy; Reuters Messaging: ; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: SYNERON FDA/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS0737